TherapeuticsMD, Inc. — Director's Dealing 2014

Dec 15, 2014

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: TherapeuticsMD, Inc. (TXMD)
CIK: 0000025743
Period of Report: 2014-12-11

Reporting Person: Donegan Michael C (Vice President Finance)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Non-qualified stock option	$2.98	2023-06-20	Common Stock (75000)		Direct
Non-qualified stock option	$5.01	2024-07-08	Common Stock (50000)		Direct

Footnotes

F1: The 75,000 shares underlying this option vest at the rate of 25,000 shares on the first, second and third anniversary of the date of grant of 6/21/13.

F2: The 50,000 shares underlying this option vest at the rate of 12,500 shares on the first, second, third and fourth anniversary of the date of grant of 7/9/14.